ENTRY       D04447            Mixture   Drug
NAME        Betamethasone and d-chlorpheniramine maleate;
            Celestamine (TN)
COMPONENT   Betamethasone [DR:D00244], d-Chlorpheniramine maleate [DR:D00668]
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2459
            ATC code: R06AB54
            Product: D04447<JP>
EFFICACY    Anti-inflammatory
COMMENT     Betamethasone is primarily metabolized by CYP3A4.
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R06 ANTIHISTAMINES FOR SYSTEMIC USE
               R06A ANTIHISTAMINES FOR SYSTEMIC USE
                R06AB Substituted alkylamines
                 R06AB54 Chlorphenamine, combinations
                  D04447  Betamethasone and d-chlorpheniramine maleate &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               245  Adrenal hormone preparations
                2459  Others
                 D04447  Betamethasone and d-chlorpheniramine maleate
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D04447  Betamethasone and d-chlorpheniramine maleate
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04447
DBLINKS     PubChem: 17398108
///
